丁香苷对H/R心肌细胞的保护作用及其机制研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

武汉市卫生计生委科研项目(WX15D30)


Expression of RECK and MMP9 in tissue microarray of triplenegative breast cancer and its clinical significance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨基质金属蛋白酶抑制剂(RECK)、基质金属蛋白酶9(MMP9)在三阴性乳腺癌(TNBC)组织、癌旁组织中的表达及与TNBC临床病理的关系。方法 选择绵阳市中心医院乳腺外科2011年5月~2013年7月经病理证实为TNBC的72例石蜡标本及同患者癌旁组织,利用免疫组化组织芯片技术检测其RECK、MMP9蛋白的表达。结果 RECK在TNBC组织及癌旁组织中阳性表达率分别为4306%、8056%(P=0000)。TNBC中RECK的表达与临床分期(P=0009)、组织学分级(P=0010)、腋窝淋巴结转移情况(P=0000)相关。MMP9在TNBC组织及癌旁组织中阳性表达率分别为625%、1528%(P=0000)。TNBC中MMP9的表达与肿瘤大小(P=0017)、临床分期(P=0001)、组织学分级(P=0001)、腋窝淋巴结转移状况(P=0001)、Ki67表达情况(P=0034)相关。TNBC中RECK与MMP9表达呈负相关(r=0195,P<005)。结论 RECK的表达缺失与MMP9过度表达与TNBC浸润、转移有关,有望成为TNBC的预后指标,并且有可能成为TNBC治疗的靶点。

    Abstract:

    【Abstract】 Objective To measure the roles of syringin (SYR) on hypoxia/reoxygenation (H/R)treated cardiomyocytes and possible mechanims. Methods Cultured cardiomyocytes were assigned into control group, H/R group and H/R+SYR group. Three hours of hypoxia and 3h of reoxygenation were performed to cause H/R injury. Cell viability, LDH release, apoptosis, ROS, inflammation and molecular alternations were systematically detected. Moreover, the specific AMPK inhibitor (Compound c) was added in mechanistic measurement. Results In comparison with the control group, H/R resulted in the reduced cell viability and increased LDH release, followed by the worsened ROS, apoptosis and inflammation. However, above parameters induced by H/R injury were significantly attenuated by SYR treatment. Mechanistic experiment showed SYR administration enhanced the level of pAMPK, and blocking AMPK with the specific inhibitor blunted H/Rrepressing effects of SYR. Conclusion SYR attenuates myocardial H/R injury in part via a AMPKdependent manner.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-03-08
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司